MileCell Biotechnology is pleased to announce its participation in the 2026 European ISSX Meeting, taking place June 29 – July 2, 2026. As one of the leading international conferences dedicated to drug metabolism, pharmacokinetics, and translational ADME sciences, ISSX Europe brings together researchers, scientists, and industry professionals focused on advancing more predictive and biologically relevant approaches to drug development.
As the ADMET community continues to seek better ways to evaluate oral bioavailability, metabolic stability, drug-drug interaction (DDI) risk, and translational predictability, the quality and biological relevance of in vitro research systems remain critical to generating meaningful data and supporting confident development decisions.
At Booth #4, MileCell will be available to discuss how our biological systems can support drug metabolism, toxicity assessment, metabolic activation, and translational ADMET workflows.
Supporting More Predictive ADMET Research
Behind every ADMET decision lies a fundamental question:
How predictive is your in vitro model?
MileCell provides a comprehensive portfolio of biological systems designed to support researchers working across drug metabolism, pharmacokinetics, toxicology, and preclinical development.
Our solutions support applications including:
· Metabolic stability studies
· Drug-drug interaction (DDI) assessment
· First-pass metabolism evaluation
· Enzyme activity characterization
· Metabolic activation studies
· Hepatotoxicity research
· Translational ADMET modeling
· Genotoxicity-related workflows
Featured ADMET Research Solutions
Primary Hepatocytes
MileCell offers both plateable and suspension hepatocytes from multiple species to support:
· Drug metabolism studies
· Clearance assessment
· CYP induction testing
· Transporter studies
· Toxicity evaluation
· In vitro-in vivo extrapolation (IVIVE)
Liver Non-Parenchymal Cells (NPCs)
Our portfolio includes:
· Kupffer Cells
· Hepatic Stellate Cells
· Liver Sinusoidal Endothelial Cells (LSECs)
· NPC Mixes
These systems support research involving liver inflammation, fibrosis, toxicity mechanisms, and disease modeling.
Subcellular Fractions
MileCell provides a broad range of subcellular fractions including:
· Liver Microsomes
· Intestine Microsomes
· S9 Fractions
· Cytosol
· Lysosomes
· Tritosomes
· Tissue Homogenates
These products are widely used in drug metabolism, enzyme activity, DDI, metabolite identification, and bioactivation studies.
Induced Liver S9 and Intestine S9 Fractions
Our induced S9 products provide biologically relevant systems for:
· Metabolic activation studies
· Genotoxicity workflows
· Reactive metabolite investigations
ADME Culture Reagents and Collagen-Coated Plates
Supporting consistent hepatocyte attachment, viability, and function, these tools help improve assay reproducibility and overall experimental performance.
Meet MileCell at Booth #4
Whether your research focuses on drug metabolism, oral bioavailability, intestinal first-pass metabolism, hepatotoxicity, or translational ADMET modeling, our team looks forward to discussing how MileCell’s biological systems can support your work.
Visit MileCell at Booth #4 during 2026 European ISSX.
To schedule a meeting in advance, please contact:
info@milecell-bio.com
We look forward to meeting fellow researchers and industry professionals and exploring opportunities to advance more predictive ADMET research together.
